| Term 
 
        |       Depolarizing neuromuscular blockers  |  | Definition 
 
        |   - AchE inhibitors  - increase levels of Ach - directly stimulate the nicotinic receptors on the skeletal muscle endplate, producing depolarization of the endplate  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   - depolarizing neuromuscular blockers  - acts by producing initial contraction followed by a paralysis of the skeletal muscle, which cannot be activated through the Nm receptor  - still used therapeutically |  | 
        |  | 
        
        | Term 
 
        |       Nondepolarizing neuromuscular blockers  |  | Definition 
 
        |   - D-tubocurare - antagonize the effects of Ach at the Nm receptor  - the endplate region of skeletal muscle remains polarized  -competitive Nm receptor antagonists    - produce flaccid paralysis     |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     - act directly on the skeletal muscle  to produce relaxation    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   - act at the motor neuron to interfere with Ach release  - Hemicholinium which inhibits Ach synthesis - Botulinus toxin  
 |  | 
        |  | 
        
        | Term 
 
        |       Depolarizing neuromuscular blocker |  | Definition 
 
        |       - Decamethonium  - not used therapeutically  |  | 
        |  | 
        
        | Term 
 
        |       Nondepolarizing neuromuscular blockers |  | Definition 
 
        |     2 groups:  - the benzylisoquinolinium compounds - the aminosteroid compounds   |  | 
        |  | 
        
        | Term 
 
        |       Benzylisoquinolinium compounds  |  | Definition 
 
        | - D-tubocurare - metocurine - alcuronium - atracurium - mivacurium - placed at the skeletal muscle endplate region (lollipop) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - Pancuronium - Vecuronium - Rocuronium - more potent - they are competitive Nm receptor antagonists - placed at the skeletal muscle endplate region (lollipop) |  | 
        |  | 
        
        | Term 
 
        |       Depolarizing neuromuscular blockers  |  | Definition 
 
        |   - produce a persistent (long-acting) depolarization  of the skeletal muscle endplate  - produce transient fasciculations -they desensitize the skeletal muscle to Ach  (Ach will bind and produce no effect) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   - Succinylcholine, it seems to mimic  the effects of Ach - it stimulates the vagal nerve, and you  get bradycardia as a potential effect |  | 
        |  | 
        
        | Term 
 
        |       Succinylcholine works in 2 phases:   |  | Definition 
 
        | Phase 1, the skeletal muscle membrane  depolarizes, you get a transient fasciculation  and flaccid paralysis. (normal agonist effect)   Phase 2, the membrane repolarizes,  but the membrane still will not respond to Ach  (is still desensitized to Ach); the effect  like the inverse agonist.   |  | 
        |  | 
        
        | Term 
 
        |       Adverse CV effects  of NM Blockers |  | Definition 
 
        | Ganglionic block: Tubocurarine, Metocurine, Alcuronium Histamine release: Tubocurarine, Metocurine, Alcuronium, Succinylcholine Vagal stimulation:Succinylcholine Sympathetic stimulation: Pancuronium |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - will cause hypotension
 - it is blocking sympathetic ganglia  (less vasoconstriction) - can be produced by Tubocurarine, Metocurine, Alcuronium |  | 
        |  | 
        
        | Term 
 
        |       Ganglionic blocker on the heart |  | Definition 
 
        | - would produce tachycardia because in  the heart, you have dual innervation and  the predominant tone to the  heart is parasympathetic, and it  will be blocked the most. So you have unopposed sympathetic stimulation.    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   - dangerous for asthmatics (should be pre-treated with a H-1 receptor antagonist) -can produce bronchoconstriction, vasodilation, hypotension |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   
 - has naked histamine receptors, - has naked muscarinic receptors  - it has naked beta 2 receptors    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |         - predominant tone is sympathetic  |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        |       Adverse effects of succinylcholine  |  | Definition 
 
        | - increased intraoccular pressure- caution in glaucoma!! - post-operative muscle pain (because of the fasciculations, which cause the contraction of the skeletal muscle) - hyperkalemia - because of the muscle contractility  - Malignant hyperthermia and succinylcholine apnea
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       - idiosyncratic response due to the abnormal pseudocholinesterase  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |    - compatible with normal cardiac function
 - can result in dangerous electrolyte  imbalances, so avoid using succinylcholine  when you have soft tissue trauma    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - occurs with halogenated hydrocarbons and succinylcholine, it’s an idiosyncratic response  - excessive calcium release from the sarcoplasmic reticulum that leads to rigidity of the muscle - also associated with hyperthermia, increased muscle metabolism, resulting metabolic acidosis, and it can result in death.  |  | 
        |  | 
        
        | Term 
 
        |       Disposition of neuromuscular blockers  |  | Definition 
 
        |   Hepatic and renal: d-tubocurare, pancuronium, rocuronium, vecuronium, are metabolized by the liver and eliminated through the kidneys.  Plasma cholinesterase is important with succinylcholine!!!  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   Succinylcholine apnea, succinylcholine-induced malignant hyperthermia, along with the halogenated hydrocarbon anaesthetics and cyclopropane – these are agents which have this unique characteristic to it.  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     - metabolized by the pseudocholinesterase  in the plasma  - given to patients with renal or liver problems |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     - metabolized by the pseudocholinesterase and  degraded spontaneously   - given to patients with renal or liver problems  |  | 
        |  | 
        
        | Term 
 
        |     Peripherally acting skeletal  muscle relaxant drug uses |  | Definition 
 
        |       - used as adjuncts to general anaesthesia, as  adjuncts to electroshock therapy  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct-acting agent, increases the binding of calcium to the sarcoplasmic reticulum and  it inhibits the movement of calcium in response to membrane depolarization     It doesn't interfere with voluntary contractions; it  interferes with tiny contractions which depend  on initial release of calcium from  the sarcoplasmic reticulum.      |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - interferes with brief, phasic contractions. It has negligible effect on sustained tettanic contractions. Contractions associated with spasticities are phasic not sustained.Used in muscle spasticities, and also used to combat malignant hyperthermia |  | 
        |  | 
        
        | Term 
 
        |       Dantrolene adverse effects: |  | Definition 
 
        | - transient drowsiness: avoid CNS depressants / driving; - hepatotoxicity; - respiratory depression with impairement of central control of respiration (in people with cervical/ high cervical lesions, or brainstem lesions)  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Botulinum toxin (Type A) Botox: given locally; works by inhibiting Ach release and causing relaxation of the skeletal muscle responsible for producing the wrinkle 
 Botulinum toxin (Type B) Myoblock Also used for: blepharospasms, strabismus, and  cervical dystonia  
 |  | 
        |  | 
        
        | Term 
 
        |       Adverse effects and precautions of botulinum toxin:   |  | Definition 
 
        | - aminoglycoside antibiotics and curare-like drugs can potentiate their effects  Curare-like drugs, by blocking the nicotinic  receptors, will potentiate the effects of  drugs which inhibit the release of Ach!! Xerostomia and dysphagia!!! |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       - potentiates the effect of d-tubocurare  |  | 
        |  |